References
- Pickup JC, Keen H, Parsons JA, et al. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J 1978: 1(6107): 204–7
- Tamborlane WV, Sherwin RS, Genel M, et al. Reduction to normal of plasma glucose in Juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979: 300(11): 573–8
- Teutsch SM, Herman WH, Dwyer DM, et al. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med 1984: 310(Feb 9): 361–8
- D'Agostino M, Bucholtz JL, Pelle A, et al. Initiation of insulin pump therapy in the ambulatory setting. Diabetes Educator 1983: 9(1): 35–7
- American Diabetes Association. Indications for use of continuous insulin delivery systems and self-measurement of blood glucose. Diabetes Care 1982: 5(2): 140–1
- Pietri A, Raskin P. Cutaneous complications of chronic continuous subcutaneous insulin infusion therapy. Diabetes Care 1981: 4(6): 624–6
- Levandoski LA, White NH, Santiago JV. Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy. Diabetes Care 1982: 5(Suppl 1): 6–10
- Reeves ML, Siegler DE, Ryan EA, et al. Glycemic control in insulin-dependent diabetes mellitus: comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 1982: 72(4): 673–80
- Nathan DM, Lou P, Avruch J. Intensive conventional and insulin pump therapies in adult type 1 diabetes: a crossover study. Ann Intern Med 1982: 97(1): 31–6
- Chantelau E, Sonnenberg GE, Stanitzek-Schmidt I, et al. Diet liberalization and metabolic control in type I diabetic outpatients treated by continuous subcutaneous insulin infusion. Diabetes Care 1982: 5(6): 612–6
- Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1982: 5(5): 479–84
- Tamborlane WV, Puklin JE, Bergman M, et al. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 1982: 5(Suppl 1): 58–64
- White NH, Waltman SR, Krupin T, et al. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control. Diabetes 1982: 31(1): 80–5
- Boulton AJ, Drury J, Clarke B, et al. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982: 5(4): 386–90
- Cohen AW, Liston RM, Mennuti MT, et al. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump. J Reprod Med 1982: 27(10): 651–4
- Mecklenburg RS, Benson JW Jr, Becker NM, et al. Clinical use of the insulin infusion pump in 100 patients with type I diabetes. N Engl J Med 1982: 307(9): 513–8
- Skyler JS, Siegler DE, Reeves ML. Optimizing pumped insulin delivery. Diabetes Care 1982: 5(2): 135–9
- American College of Physicians. Board oks Statement on diabetes. Observer 1983: 3(7): 1–21